ClinicalTrials.gg
Drug

Camostat clinical trials

Also written FOY-305 and DWJ1248.

studies test it
25
open now
1
in phase 3
7
first study started
2020

How each study uses camostat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the camostat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Camostat Mesilate
10
Camostat Mesylate
7
Camostat
6
Foipan
5

Development codes

FOY-305
3
DWJ1248
2

Studies by the year they started

25 studies that test it; most in 2020 (14)

Studies that test camostat, by start year
YearStudies
202014
20219
20221
20241

By phase

A phase 1/2 study counts in both.

Phase 1
4
Phase 2
16
Phase 3
7
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 6 · Other 19

Stanford University (3) · Daewoong Pharmaceutical Co. LTD. (3) · Ono Pharmaceutical Co. Ltd (2) · Yale University (2) · Heinrich-Heine University, Duesseldorf (2) · University of Aarhus (1) · Seoul National University Hospital (1) · Alan Bryce (1)

Often tested with

Tested in the same studies.

Bamlanivimab (1) · Amubarvimab (1) · Romlusevimab (1) · Cilgavimab and tixagevimab drug combination (1) · Interferon beta-1a (1) · Interferon Beta-1a Inhalation Solution SNG001 (1) · Ogalvibart (1) · Crexavibart (1)

Related medicines

As reviewed, each with the page that says it.

Studies

Open first, then newest update. How each study uses camostat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 25

See all 25 studies that test camostat →

As the comparator · 1 — what is tested is compared with camostat

Codes

What other systems call camostat · ClinicalTrials.gg INT003030

  • MeSH (NLM) C034532camostatConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 0FD207WKDUCAMOSTATConfirmed FDA, NLM, Wikidata
  • Wikidata Q5026909camostatConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C73213CamostatOne source FDA
  • DrugBank DB13729One source Wikidata

Also registered as camostat mesylate (UNII 451M50A1EQ).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.